Research Grants 4 show all


$187.2K
2012

$139.5K
2013

$1.1M
2014

Patents 167show all

  • 90
    A61K - Preparations for medical, dental, or toilet purposes
  • 78
    C08G - Macromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds
  • 51
    C08L - Compositions of macromolecular compounds
  • 22
    C12N - Microorganisms or enzymes
  • 21
    C07D - Heterocyclic compounds
  • 17
    C07C - Acyclic or carbocyclic compounds
  • 17
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 15
    C08J - Working-up
  • 13
    C08F - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
  • 7
    B82Y - Specific uses or applications of nanostructures

Clinical Trials 1show all

1Phase 1

SEC Filings show all


2
D

Contact Information

Tampa, FL
United States

SEC Form D Funding Events

DateOfferedSoldType
2013-06-25$8,844,359$8,844,359Equity

Key Executives

  • Habib Skaff
    Executive Officer, Director
  • Michael Fountain
    Director
  • James Trotman
    Director
  • Micheal Cole
    Director
  • Kevin Sill
    Executive Officer, Director
  • Hooshmand Sheshbaradaran
    Director
  • John McBride
    Director
  • Daniel Devers
    Executive Officer